Literature DB >> 18079210

Loss of function in virus-specific lung effector T cells is independent of infection.

Subhashini Arimilli1, Ellen M Palmer, Martha A Alexander-Miller.   

Abstract

Recently, several studies, including those with respiratory syncytial virus, mouse pneumovirus, and simian virus 5, have reported that virus-specific CD8+ effector cells entering the lung as a result of respiratory infection undergo significant loss of function. The impaired function in these cells has been proposed to be the result of infection-induced changes in the lung. Although virus-specific effects may contribute to regulation of T cells in the lung, the findings from this study provide evidence that the basal lung environment is sufficient to promote loss of function in effector cells. Loss of function occurs within 48 h of entry into the lung and is most evident in cells residing in the lung parenchyma. These findings suggest an additional paradigm for the immunoregulation of effector cells that enter the lung as a result of virus infection.

Entities:  

Mesh:

Year:  2007        PMID: 18079210     DOI: 10.1189/jlb.0407215

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Editorial: CD8 T cells cut back on calcium intake in the lungs.

Authors:  Ross B Fulton; Steven M Varga
Journal:  J Leukoc Biol       Date:  2010-06       Impact factor: 4.962

2.  Differentiation-dependent differences in murine T cell susceptibility to negative regulation by the lung.

Authors:  Rhea Y Busick; Rama D Yammani; Martha A Alexander-Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-07       Impact factor: 6.914

3.  Regulation of cytokine production by virus-specific CD8 T cells in the lungs.

Authors:  Ross B Fulton; Matthew R Olson; Steven M Varga
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

4.  Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1.

Authors:  Subhashini Arimilli; Sharad K Sharma; Rama Yammani; Sean D Reid; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Leukoc Biol       Date:  2010-01-26       Impact factor: 4.962

Review 5.  Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.

Authors:  Martha A Alexander-Miller
Journal:  J Immunol       Date:  2014-12-01       Impact factor: 5.422

Review 6.  The host response and molecular pathogenesis associated with respiratory syncytial virus infection.

Authors:  Christine M Oshansky; Wenliang Zhang; Elizabeth Moore; Ralph A Tripp
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

7.  Memory CD4 T cell-derived IL-2 synergizes with viral infection to exacerbate lung inflammation.

Authors:  K Kai McKinstry; Fahmida Alam; Valeria Flores-Malavet; Mate Z Nagy; Stewart Sell; Andrea M Cooper; Susan L Swain; Tara M Strutt
Journal:  PLoS Pathog       Date:  2019-08-14       Impact factor: 6.823

Review 8.  Reining in the CD8+ T cell: Respiratory virus infection and PD-1-mediated T-cell impairment.

Authors:  Meredith C Rogers; John V Williams
Journal:  PLoS Pathog       Date:  2019-01-03       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.